# Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome

> **NCT03122652** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 125 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Teriflunomide 14 MG Oral Tablet [Aubagio]
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03122652
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-25
- **Primary completion:** 2019-02-05
- **Final completion:** 2022-10-04
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2023-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122652, "Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03122652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*